14-39240572-G-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000640607.2(MIA2):c.261G>T(p.Glu87Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000937 in 1,610,780 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000640607.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MIA2 | NM_001329214.4 | c.261G>T | p.Glu87Asp | missense_variant | 3/29 | ENST00000640607.2 | NP_001316143.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIA2 | ENST00000640607.2 | c.261G>T | p.Glu87Asp | missense_variant | 3/29 | 1 | NM_001329214.4 | ENSP00000491014 | P2 | |
MIA2 | ENST00000280082.4 | c.261G>T | p.Glu87Asp | missense_variant | 3/6 | 1 | ENSP00000280082 | |||
MIA2 | ENST00000553728.1 | c.261G>T | p.Glu87Asp | missense_variant | 3/28 | 5 | ENSP00000452252 | A2 | ||
MIA2 | ENST00000557148.5 | c.261G>T | p.Glu87Asp | missense_variant | 5/5 | 5 | ENSP00000451883 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250628Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135428
GnomAD4 exome AF: 0.0000994 AC: 145AN: 1458568Hom.: 0 Cov.: 28 AF XY: 0.000103 AC XY: 75AN XY: 725814
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152212Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74364
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 27, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at